.png){kind=icon}
.png){kind=icon}
Return
Untitled - Response
.png){kind=icon}
PRE
AI
DOI：10.1093/jnci/djn161.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
REDUCTASE INHIBITORS
CONTROLLED TRIAL
RISK
INDIVIDUALS
SIMVASTATIN
PRAVASTATIN
DISEASE
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.2
Papers:
6.2K
Citations:
3.3W